From Testing to Targeted Treatments is a collective program that aims to make targeted medicine an accessible reality in oncology and beyond.

The Motherhood Collective Impact Programme aims to empower all motherhood stakeholders, from grassroots groups to advocacy and large organisations, to accelerate impact and avoid duplication.

PFMD aims to transform the way in which we understand, engage, and partner with patients globally in the design and development of research and medicines by focusing on unmet patient needs.

Break Dengue aims to connect different initiatives around the world that are addressing the issue of dengue so that together they can have a bigger impact.

Gravitate Health aims to equip and empower citizens with digital information tools that make them confident, active, and responsive in their patient journey, specifically encouraging safe use of medicines for better health outcomes and quality of life.

Share4Rare is a collective online platform with the ambition to make a difference for rare disease patients and their families.

PARADIGM aims to provide a unique framework that enables structured, effective, meaningful, ethical, innovative and sustainable patient engagement.

IMI Conception

IMI Conception is a five-year project that aims to tackle the fragmented landscape around medication in pregnancy and breastfeeding.

Synchros

Synchros is a three-year project that aims to map the cohort landscape in Europe and large international initiatives, identify best methods for integrating cohort data followed by the solutions to address challenges arising in integrating data across patient, clinical trial and population cohorts.